Anzeige
Mehr »
Dienstag, 21.07.2026 - Börsentäglich über 12.000 News
+50% in 13 Tagen - Steht der große Ausbruch jetzt bevor?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
85 Leser
Artikel bewerten:
(0)

Conquering Biopharma's 'Mount Everest': The Human Element of Digital Transformation

CAMBRIDGE, Mass. and CAMBRIDGE, England, July 21, 2026 /PRNewswire/ -- As the Biopharma industry adopt advanced technologies at breakneck speeds, organizations are running into a surprising roadblock. It isn't the technology. It's human behavior. In a recent Zifo virtual panel discussion, 'Change Management Strategies Elevating Digital Transformation in Pharma,' Zifo experts decoded exactly why technological investments often fall flat, and how robust change management is the true secret to real-world success.

Host Shivani Vohra, Zifo's Consultant Analyst, opened the session with a comparison, likening Biopharma digital transformation to climbing Mount Everest. "The goal is clear... but the success of that mission does not depend only on the climb itself," Shivani noted. "It depends entirely on the preparation that has happened at the base," she added.

Core Themes and Key Takeaways from the discussion:

1. Macro Vision vs. Micro Execution

Successful digital transformation requires a balanced approach. While leadership must set a clear, long-term strategic 'North Star' (the macro vision), the ability to realize this vision falls short unless leaders actively address the granular, day-to-day workflow frictions (the micro execution) that scientists face at the bench.

Zifo's Change Practitioner, Harsha Nirmal Kumar, emphasized how true transformation requires balancing the boardroom's 'why' with the bench scientist's daily 'how.'

2. Reframing Resistance as a Health Check

Rather than viewing user pushback as behavioral sabotage, the speakers reframe it as a vital health check. As the discussion highlighted, 'Resistance is not troublemaking; rather, it is a signal that a piece of the adoption puzzle is missing.' Understanding what is driving the resistance is an important first step in figuring out how to best support the scientists through the transition.

Zifo's Shari Bickford, a specialist in change leadership, shared a case study of a lab team fiercely resisting a new digital rollout. By digging deeper via a focus group, the project team discovered the resistance stemmed from a poorly managed past software transition that left the scientists stuck with unresolved workarounds for years. The team was then able to proactively establish supports for the team to make this transition smoother for them.

3. Governance vs. Operationalization

Governance frameworks (policies, compliance charters, and audit readiness) act as essential enterprise guardrails. However, these blueprints would remain hollow without the human element for operationalization: building user habits, setting up governance council, and using adaptive tools (like Jira and Confluence) to make adoption seamless.

Harsha outlined this as an intersection of people and policies, noting that terms like COMPLIANCE shouldn't frighten users; He also emphasized, "Policies should be guardrails that guide people. They should not impede your progress."

4. The Transformation Toolkit

To successfully pull high-stakes digital initiatives out of 'pilot purgatory' and scale them globally, organizations need agile, tactical frameworks. Shari highlighted models like vision and value workshops (what the transition is fundamentally intended to accomplish and how does the organization define concrete metrics of success beyond technical deployment), dynamic stakeholder mapping (knowing how to reach all segments of the audience through balancing user buy-in against enterprise influence), and the CDV (Communicate, Demonstrate, Validate) framework to support leaders in knowing how to best drive change.

Tech Alone Cannot Drive Transformation

Ultimately, the virtual panel discussion hammered home one vital truth. Technology alone cannot drive transformation. True success requires a structured, empathetic, and people-first approach that brings the entire community along for the journey. Bringing along the community during the transition will lead to better adoption, in turn driving overall success.

To watch the full discussion, please visit: https://zifo.com/blogs/accelerating-digital-transformation-with-strategic-change-management-in-pharma/

About Zifo

Zifo is the leading global enabler of AI and data driven enterprise informatics for science driven organizations. With extensive solutions and services expertise spanning research, development, manufacturing, and clinical domains, we serve a diverse range of industries, including Pharma, Biotech, Chemicals, Food and Beverage, Oil & Gas, and FMCG. Trusted by over 190 science-focused organizations worldwide, Zifo is the partner of choice for advancing digital scientific innovation. https://zifo.com/ and https://zifo.com/practical-ai-blueprints/

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/conquering-biopharmas-mount-everest-the-human-element-of-digital-transformation-302830766.html

© 2026 PR Newswire
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.